Blood Transfusion Associated Diseases and Complications in Thalassaemia Patients
Abstract
Background: Transfusion Transmitted Infections (TTIs) are going to hit as a major risk factor in overpopulated regions of the world comprising thalassaemia as a main concern. The variety of infectious diseases that transfer from blood donors to thalassaemia patients leading complications which result in delay hemolytic transfusion reactions and different types of infections whose causative agents may be HBV, HCV, HIV and Syphilis etc.
Epidemiology: The thalassaemia affects almost 4.4 of every 10000 births worldwide although its rate in Pakistan is 5000 to 10000 births per year with 5-7 % estimated carrier rate. The blood transfusion and transmissible infections ratio in low income countries is as, HIV presence is from 0.33% to 1.66%, HBV presence is from 2.00% to 4.50%, HCV presence is from 0.50% to2.23% and Syphilis presence is from 0.60% to 1.81%.
Diagnostics: The Immuno-chromatographic tests are affordable and can be valid to be used for blood screening throughout world. Blood samples should be processed for a counter check via ELISA/ CLIA and NAT technique to eliminate risk of HBV, HCV, HIV and syphilis deadly infections.
Treatment: Patients must be provided regular blood transfusion to keep average hemoglobin level at 10-12 g/dl. Other treatments include Iron Chelation therapy which is mandatory for better life expectancy as well as splenectomy, stem cell transplant and gene therapy.
Conclusion: The blood transfusion infections based on ICT (Immuno-chromatographic technique) prove unreliable while CLIA (ChemiluminescenceImmunoassay) is reliable comparatively due to capturing weak positive and low titer infectious agents. In order to avoid the delayed hemolytic transfusion reactions it is enforced to detect the subgroups of blood like A (A1 and A2) and AB (A1B and A2B).
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.
On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/
